发明名称 18-Methyl-19-norandrost-4-ene 17, 17-spiro ether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the same
摘要 The present invention describes the novel 18-methyl-19-norandrost-4-ene 17,17-spiro ethers of the general formula I in which Z is an oxygen atom, two hydrogen atoms, a group ═NOR or ═NNHSO2R, where R is a hydrogen atom or a straight- or branched-chain alkyl group having 1 to 4 or 3 to 4 carbon atoms, R4 is a hydrogen atom, a halogen atom or a trifluoromethyl group, and R6 and/or R7 may have α or &bgr; configuration, and R6 and R7 are independently of one another a hydrogen atom or a straight- or branched-chain alkyl group having 1 to 4 or 3 to 4 carbon atoms or a straight- or branched-chain alkenyl group having 2 to 4 or 3 to 4 carbon atoms or a saturated cycloalkyl group having 3 to 5 carbon atoms or together are a methylene group or a double bond. The novel compounds have progestational and antimineralocorticoid activity.
申请公布号 US7846917(B2) 申请公布日期 2010.12.07
申请号 US20070769952 申请日期 2007.06.28
申请人 BAYER SCHERING PHARMA AG 发明人 BOHLMANN ROLF;KUHNKE JOACHIM;HUEBNER JAN;GALLUS NORBERT;MENGES FREDERIK;BORDEN STEFFEN;MUHN HANS-PETER;PRELLE KATJA
分类号 A61K31/58;C07J21/00 主分类号 A61K31/58
代理机构 代理人
主权项
地址